Holdings (Monthly)
Guide ↗
Invesco Health Care Fund
· AIM Investment Funds (Invesco Investment Funds)| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly and Co. | 532457108 | Apr 2025 | 113,267 | $117.5M | 9.55% | EC |
| 2 | Boston Scientific Corp. | 101137107 | Apr 2025 | 670,569 | $62.7M | 5.10% | EC |
| 3 | AbbVie Inc. | 00287Y109 | Apr 2025 | 277,017 | $61.8M | 5.02% | EC |
| 4 | Cencora, Inc. | 03073E105 | Apr 2025 | 162,214 | $58.3M | 4.73% | EC |
| 5 | Gilead Sciences, Inc. | 375558103 | Apr 2025 | 337,004 | $47.8M | 3.89% | EC |
| 6 | AstraZeneca PLC | 046353108 | Apr 2025 | 504,742 | $46.8M | 3.80% | EC |
| 7 | argenx SE | 04016X101 | Apr 2025 | 52,976 | $44.5M | 3.62% | EC |
| 8 | Johnson & Johnson | 478160104 | Jan 2026 | 184,830 | $42.0M | 3.41% | EC |
| 9 | McKesson Corp. | 58155Q103 | Apr 2025 | 47,553 | $39.5M | 3.21% | EC |
| 10 | Invesco Private Prime Fund | N/A | Apr 2025 | 30,856,835 | $30.9M | 2.51% | STIV |
| 11 | Thermo Fisher Scientific Inc. | 883556102 | Apr 2025 | 49,606 | $28.7M | 2.33% | EC |
| 12 | HCA Healthcare, Inc. | 40412C101 | Apr 2025 | 49,432 | $24.1M | 1.96% | EC |
| 13 | Intuitive Surgical, Inc. | 46120E602 | Apr 2025 | 45,537 | $23.0M | 1.87% | EC |
| 14 | Invesco Treasury Portfolio | 825252406 | Apr 2025 | 22,695,004 | $22.7M | 1.84% | STIV |
| 15 | Welltower Inc. | 95040Q104 | Apr 2025 | 120,441 | $22.7M | 1.84% | EC |
| 16 | Guardant Health, Inc. | 40131M109 | Apr 2025 | 189,772 | $21.6M | 1.76% | EC |
| 17 | Ascendis Pharma A/S | 04351P101 | Apr 2025 | 94,558 | $21.4M | 1.74% | EC |
| 18 | Natera, Inc. | 632307104 | Apr 2025 | 86,013 | $19.9M | 1.62% | EC |
| 19 | IDEXX Laboratories, Inc. | 45168D104 | Apr 2025 | 29,150 | $19.5M | 1.59% | EC |
| 20 | BrightSpring Health Services, Inc. | 10950A106 | Apr 2025 | 482,157 | $18.9M | 1.54% | EC |
| 21 | Insmed Inc. | 457669307 | Apr 2025 | 120,502 | $18.9M | 1.54% | EC |
| 22 | Royalty Pharma PLC | G7709Q104 | Apr 2025 | 440,990 | $18.4M | 1.49% | EC |
| 23 | U C B S.A. | N/A | Apr 2025 | 58,259 | $17.8M | 1.44% | EC |
| 24 | UnitedHealth Group Inc. | 91324P102 | Apr 2025 | 59,237 | $17.0M | 1.38% | EC |
| 25 | BridgeBio Pharma, Inc. | 10806X102 | Apr 2025 | 216,227 | $16.7M | 1.36% | EC |
| 26 | Axsome Therapeutics, Inc. | 05464T104 | Apr 2025 | 87,700 | $16.2M | 1.31% | EC |
| 27 | Tenet Healthcare Corp. | 88033G407 | Apr 2025 | 80,222 | $15.2M | 1.23% | EC |
| 28 | Vertex Pharmaceuticals Inc. | 92532F100 | Apr 2025 | 32,280 | $15.2M | 1.23% | EC |
| 29 | Alnylam Pharmaceuticals, Inc. | 02043Q107 | Apr 2025 | 42,329 | $14.3M | 1.16% | EC |
| 30 | Encompass Health Corp. | 29261A100 | Apr 2025 | 143,359 | $13.6M | 1.10% | EC |
| 31 | Insulet Corp. | 45784P101 | Apr 2025 | 52,804 | $13.5M | 1.10% | EC |
| 32 | Regeneron Pharmaceuticals, Inc. | 75886F107 | Jan 2026 | 18,122 | $13.4M | 1.09% | EC |
| 33 | Mettler-Toledo International Inc. | 592688105 | Apr 2025 | 9,732 | $13.4M | 1.09% | EC |
| 34 | Stryker Corp. | 863667101 | Apr 2025 | 34,934 | $12.9M | 1.05% | EC |
| 35 | United Therapeutics Corp. | 91307C102 | Jan 2026 | 26,773 | $12.6M | 1.02% | EC |
| 36 | Sandoz Group AG | H7140B103 | Apr 2025 | 150,537 | $11.9M | 0.97% | EC |
| 37 | Invesco Private Government Fund | N/A | Apr 2025 | 11,873,857 | $11.9M | 0.96% | STIV |
| 38 | Invesco Government & Agency Portfolio | 825252885 | Apr 2025 | 11,868,147 | $11.9M | 0.96% | STIV |
| 39 | Agilent Technologies, Inc. | 00846U101 | Jan 2026 | 87,517 | $11.7M | 0.95% | EC |
| 40 | Edwards Lifesciences Corp. | 28176E108 | Jan 2026 | 140,197 | $11.4M | 0.93% | EC |
| 41 | Halozyme Therapeutics, Inc. | 40637H109 | Apr 2025 | 155,098 | $11.1M | 0.90% | EC |
| 42 | Madrigal Pharmaceuticals, Inc. | 558868105 | Jan 2026 | 21,162 | $10.4M | 0.84% | EC |
| 43 | Lonza Group AG | N/A | Apr 2025 | 14,888 | $10.1M | 0.82% | EC |
| 44 | Cardinal Health, Inc. | 14149Y108 | Jan 2026 | 44,523 | $9.6M | 0.78% | EC |
| 45 | Galderma Group AG | H3301B107 | Jan 2026 | 49,726 | $9.3M | 0.75% | EC |
| 46 | CVS Health Corp. | 126650100 | Jan 2026 | 119,228 | $8.9M | 0.72% | EC |
| 47 | Ionis Pharmaceuticals, Inc. | 462222100 | Jan 2026 | 107,312 | $8.9M | 0.72% | EC |
| 48 | Protagonist Therapeutics, Inc. | 74366E102 | Apr 2025 | 103,952 | $8.5M | 0.69% | EC |
| 49 | Steris PLC | G8473T100 | Jan 2026 | 29,417 | $7.7M | 0.63% | EC |
| 50 | Ligand Pharmaceuticals Inc. | 53220K504 | Apr 2025 | 40,048 | $7.7M | 0.63% | EC |
| 51 | Repligen Corp. | 759916109 | Apr 2025 | 50,803 | $7.6M | 0.62% | EC |
| 52 | Alignment Healthcare, Inc. | 01625V104 | Apr 2025 | 323,803 | $7.3M | 0.59% | EC |
| 53 | IRhythm Holdings, Inc. | 450056106 | Jan 2026 | 47,015 | $7.3M | 0.59% | EC |
| 54 | Medpace Holdings, Inc. | 58506Q109 | Jan 2026 | 12,424 | $7.2M | 0.59% | EC |
| 55 | Labcorp Holdings Inc. | 504922105 | Apr 2025 | 22,180 | $6.0M | 0.49% | EC |
| 56 | Globus Medical, Inc. | 379577208 | Apr 2025 | 65,282 | $5.9M | 0.48% | EC |
| 57 | Tarsus Pharmaceuticals, Inc. | 87650L103 | Apr 2025 | 77,845 | $5.0M | 0.41% | EC |
| 58 | GeneDx Holdings Corp. | 81663L200 | Apr 2025 | 50,738 | $4.9M | 0.40% | EC |
| 59 | Icon PLC | G4705A100 | Jan 2026 | 25,368 | $4.6M | 0.37% | EC |
| 60 | TransMedics Group, Inc. | 89377M109 | Jan 2026 | 33,601 | $4.5M | 0.37% | EC |
| 61 | RadNet, Inc. | 750491102 | Apr 2025 | 62,732 | $4.4M | 0.36% | EC |
| 62 | Exelixis, Inc. | 30161Q104 | Apr 2025 | 96,756 | $4.0M | 0.33% | EC |
| 63 | Quest Diagnostics Inc. | 74834L100 | Jan 2026 | 20,984 | $3.9M | 0.32% | EC |
| 64 | LeMaitre Vascular, Inc. | 525558201 | Apr 2025 | 44,039 | $3.7M | 0.30% | EC |
| 65 | HealthEquity, Inc. | 42226A107 | Apr 2025 | 43,670 | $3.7M | 0.30% | EC |
| 66 | Heartflow, Inc. | 42238D107 | Jan 2026 | 121,178 | $3.6M | 0.29% | EC |
| 67 | Nuvalent, Inc. | 670703107 | Jan 2026 | 33,246 | $3.4M | 0.28% | EC |
| 68 | BioLife Solutions, Inc. | 09062W204 | Apr 2025 | 151,657 | $3.3M | 0.27% | EC |
| 69 | BeOne Medicines Ltd. | 07725L102 | Jan 2026 | 9,251 | $3.1M | 0.26% | EC |
| 70 | Rhythm Pharmaceuticals, Inc. | 76243J105 | Jan 2026 | 30,683 | $3.1M | 0.26% | EC |
| 71 | Cytokinetics, Inc. | 23282W605 | Apr 2025 | 48,114 | $3.0M | 0.25% | EC |
| 72 | Rapport Therapeutics, Inc. | 75383L102 | Jan 2026 | 109,966 | $2.9M | 0.24% | EC |
| 73 | Cogent Biosciences, Inc. | 19240Q201 | Jan 2026 | 74,261 | $2.7M | 0.22% | EC |
| 74 | Revolution Medicines, Inc. | 76155X100 | Jan 2026 | 27,141 | $2.6M | 0.21% | EC |
| 75 | Caris Life Sciences, Inc. | 142152107 | Jan 2026 | 110,484 | $2.6M | 0.21% | EC |
| 76 | Phathom Pharmaceuticals, Inc. | 71722W107 | Apr 2025 | 184,910 | $2.5M | 0.21% | EC |
| 77 | ADMA Biologics, Inc. | 000899104 | Apr 2025 | 136,705 | $2.4M | 0.19% | EC |
| 78 | Arrowhead Pharmaceuticals, Inc. | 04280A100 | Jan 2026 | 18,515 | $1.3M | 0.10% | EC |
| 79 | BillionToOne, Inc. | 090168105 | Jan 2026 | 14,768 | $1.2M | 0.10% | EC |